Nuformix Plc (GB:NFX) has released an update.
Nuformix plc has announced that its directors have participated in a recent fundraising effort, purchasing substantial shares as part of a £300,000 placement. Notably, Non-Executive Chairman Julian Gilbert and Non-Executive Director Maddy Kennedy each acquired 22 million shares, while Executive Director Dan Gooding purchased 12 million shares. This move underscores the company’s focus on drug repurposing in fibrosis and oncology, potentially signaling confidence in its strategic direction.
For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Super Micro Computer (SMCI) Says Special Committee Found No Evidence of Fraud
- Netflix’s France and Netherlands Offices Raided for Possible Tax Fraud
- Class Action Lawsuit Against Bumble Inc. (NASDAQ:BMBL)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
